121 related articles for article (PubMed ID: 22915142)
1. A combined approach for the study of histone deacetylase inhibitors.
Činčárová L; Lochmanová G; Nováková K; Šultesová P; Konečná H; Fajkusová L; Fajkus J; Zdráhal Z
Mol Biosyst; 2012 Nov; 8(11):2937-45. PubMed ID: 22915142
[TBL] [Abstract][Full Text] [Related]
2. Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry.
Naldi M; Andrisano V; Fiori J; Calonghi N; Pagnotta E; Parolin C; Pieraccini G; Masotti L
J Chromatogr A; 2006 Sep; 1129(1):73-81. PubMed ID: 16887128
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors promote osteoblast maturation.
Schroeder TM; Westendorf JJ
J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
[TBL] [Abstract][Full Text] [Related]
4. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.
Eikel D; Lampen A; Nau H
Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors and cancer: from cell biology to the clinic.
Hess-Stumpp H
Eur J Cell Biol; 2005 Mar; 84(2-3):109-21. PubMed ID: 15819394
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of histone deacetylases.
Huang Y; Shaw PG; Davidson NE
Methods Mol Biol; 2011; 791():297-311. PubMed ID: 21913088
[TBL] [Abstract][Full Text] [Related]
7. The activity of antiepileptic drugs as histone deacetylase inhibitors.
Eyal S; Yagen B; Sobol E; Altschuler Y; Shmuel M; Bialer M
Epilepsia; 2004 Jul; 45(7):737-44. PubMed ID: 15230695
[TBL] [Abstract][Full Text] [Related]
8. The HDAC class I-specific inhibitor entinostat (MS-275) effectively relieves epigenetic silencing of the LAT2 gene mediated by AML1/ETO.
Duque-Afonso J; Yalcin A; Berg T; Abdelkarim M; Heidenreich O; Lübbert M
Oncogene; 2011 Jul; 30(27):3062-72. PubMed ID: 21577204
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel isoform-selective inhibitors within class I histone deacetylases.
Hu E; Dul E; Sung CM; Chen Z; Kirkpatrick R; Zhang GF; Johanson K; Liu R; Lago A; Hofmann G; Macarron R; de los Frailes M; Perez P; Krawiec J; Winkler J; Jaye M
J Pharmacol Exp Ther; 2003 Nov; 307(2):720-8. PubMed ID: 12975486
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of xenograft tumor radiosensitivity by the histone deacetylase inhibitor MS-275 and correlation with histone hyperacetylation.
Camphausen K; Scott T; Sproull M; Tofilon PJ
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6066-71. PubMed ID: 15447991
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases.
Göttlicher M
Ann Hematol; 2004; 83 Suppl 1():S91-2. PubMed ID: 15124690
[TBL] [Abstract][Full Text] [Related]
13. Carbamazepine is an inhibitor of histone deacetylases.
Beutler AS; Li S; Nicol R; Walsh MJ
Life Sci; 2005 May; 76(26):3107-15. PubMed ID: 15850602
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension.
Lee HA; Lee DY; Cho HM; Kim SY; Iwasaki Y; Kim IK
Circ Res; 2013 Mar; 112(7):1004-12. PubMed ID: 23421989
[TBL] [Abstract][Full Text] [Related]
15. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species.
Kang J; Chen J; Shi Y; Jia J; Zhang Y
Biochem Pharmacol; 2005 Apr; 69(8):1205-13. PubMed ID: 15794941
[TBL] [Abstract][Full Text] [Related]
16. Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors.
Naldi M; Calonghi N; Masotti L; Parolin C; Valente S; Mai A; Andrisano V
Proteomics; 2009 Dec; 9(24):5437-45. PubMed ID: 19834889
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of histone deacetylase-1 selective histone modifications by differential mass spectrometry.
Lee AY; Paweletz CP; Pollock RM; Settlage RE; Cruz JC; Secrist JP; Miller TA; Stanton MG; Kral AM; Ozerova ND; Meng F; Yates NA; Richon V; Hendrickson RC
J Proteome Res; 2008 Dec; 7(12):5177-86. PubMed ID: 19367703
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells.
Baradari V; Huether A; Höpfner M; Schuppan D; Scherübl H
Endocr Relat Cancer; 2006 Dec; 13(4):1237-50. PubMed ID: 17158768
[TBL] [Abstract][Full Text] [Related]
19. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
[TBL] [Abstract][Full Text] [Related]
20. MS275 enhances cytotoxicity induced by 5-fluorouracil in the colorectal cancer cells.
Flis S; Gnyszka A; Flis K; Spławiński J
Eur J Pharmacol; 2010 Feb; 627(1-3):26-32. PubMed ID: 19853597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
